Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
NRIX holding history
Nurix Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NRIX overviewAll 13F holders of NRIXFull Q2 2026 holdings
- Shares (Q2 2026)
- 967,620
- Value
- $23.5M
- % of portfolio
- 1.1%
- Quarters held
- 15
- Since Q4 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 967,620 | $23.5M | 1.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 967,620 | $15.0M | 0.9% | 00.0% | Unchanged | Holders |
| Q4 2025 | 967,620 | $18.4M | 1.3% | 00.0% | Unchanged | Holders |
| Q3 2025 | 967,620 | $8.94M | 0.8% | 00.0% | Unchanged | Holders |
| Q2 2025 | 967,620 | $11.0M | 1.6% | +156,951+19.4% | Added | Holders |
| Q1 2025 | 810,669 | $9.63M | 1.5% | −129,414−13.8% | Reduced | Holders |
| Q4 2024 | 940,083 | $17.7M | 2.8% | +79,684+9.3% | Added | Holders |
| Q3 2024 | 860,399 | $19.3M | 3.0% | −51,601−5.7% | Reduced | Holders |
| Q2 2024 | 912,000 | $19.0M | 3.0% | +101,747+12.6% | Added | Holders |
| Q1 2024 | 810,253 | $11.9M | 1.9% | +120,141+17.4% | Added | Holders |
| Q4 2023 | 690,112 | $7.12M | 1.4% | +440,112+176.0% | Added | Holders |
| Q3 2023 | 250,000 | $1.97M | 0.6% | +150,000+150.0% | Added | Holders |
| Q2 2023 | 100,000 | $999.0K | 0.4% | −50,000−33.3% | Reduced | Holders |
| Q1 2023 | 150,000 | $1.33M | 0.5% | +70,000+87.5% | Added | Holders |
| Q4 2022 | 80,000 | $878.4K | 0.4% | +80,000 | New | Holders |